AI-generated summary
Fourteen Asian subjects with lentigines or acquired bilateral nevus of Ota-like macules were treated split-face, with a picosecond laser on one side and a Q-switched laser on the other. The authors report that clinical improvement differed between the two systems at weeks 4, 12 and 24, with 85.7% of picosecond sites and 57.2% of Q-switched sites showing over 50% improvement at 6 months, and that the picosecond laser seemed more effective and better tolerated.
- Who or what was studied
- Asian adults with epidermal lentigines or acquired bilateral nevus of Ota-like macules
- Limits stated in the abstract
- The abstract describes a small sample of 14 subjects and relies on subjective assessments of pigment clearance, without stating a wavelength.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.